Otitis Media Studies Should Require Tympanocentesis ( Advisory Cmte.
Executive Summary
Otitis media drug trials should require repeat tympanocentesis to assess a clinical and microbiological outcome of therapy, FDA's Anti-Infective Drugs Advisory Committee decided July 29.